tiprankstipranks
Trending News
More News >
Ironwood Pharma (IRWD)
NASDAQ:IRWD
US Market

Ironwood Pharma (IRWD) Ratios

Compare
420 Followers

Ironwood Pharma Ratios

IRWD's free cash flow for Q4 2025 was $0.99. For the 2025 fiscal year, IRWD's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.13 1.13 4.69 0.84 30.58
Quick Ratio
1.13 1.13 4.69 0.84 30.53
Cash Ratio
0.89 0.89 2.28 0.33 25.71
Solvency Ratio
0.04 0.04 <0.01 -1.22 0.39
Operating Cash Flow Ratio
0.52 0.52 2.67 0.66 10.73
Short-Term Operating Cash Flow Coverage
0.63 0.63 0.00 0.92 0.00
Net Current Asset Value
$ -384.56M$ -384.56M$ -469.88M$ -584.08M$ 332.49M
Leverage Ratios
Debt-to-Assets Ratio
1.51 1.51 1.71 1.52 0.38
Debt-to-Equity Ratio
-2.28 -2.28 -1.99 -2.07 0.64
Debt-to-Capital Ratio
1.78 1.78 2.01 1.94 0.39
Long-Term Debt-to-Capital Ratio
3.13 3.13 2.07 3.28 0.38
Financial Leverage Ratio
-1.52 -1.52 -1.16 -1.36 1.69
Debt Service Coverage Ratio
0.32 0.25 1.01 0.52 24.23
Interest Coverage Ratio
3.00 3.63 2.82 -43.71 32.95
Debt to Market Cap
1.19 1.08 0.83 0.39 0.21
Interest Debt Per Share
3.89 3.89 3.98 4.74 2.74
Net Debt to EBITDA
3.13 3.65 5.23 3.16 -0.92
Profitability Margins
Gross Profit Margin
90.58%99.36%97.85%98.61%99.65%
EBIT Margin
40.66%34.70%27.24%44.23%63.33%
EBITDA Margin
41.30%35.34%27.81%44.59%63.67%
Operating Profit Margin
33.18%40.10%26.50%-213.54%60.97%
Pretax Profit Margin
23.65%23.65%18.55%-214.14%61.48%
Net Profit Margin
8.11%8.11%0.25%-226.37%42.64%
Continuous Operations Profit Margin
8.11%8.11%0.25%-233.00%42.64%
Net Income Per EBT
34.30%34.30%1.35%105.71%69.35%
EBT Per EBIT
71.27%58.96%70.01%100.28%100.83%
Return on Assets (ROA)
6.05%6.05%0.25%-212.76%15.91%
Return on Equity (ROE)
-8.22%-9.17%-0.29%289.42%26.83%
Return on Capital Employed (ROCE)
63.52%76.78%29.84%-484.91%23.29%
Return on Invested Capital (ROIC)
9.42%11.39%0.40%-237.75%16.10%
Return on Tangible Assets
6.08%6.08%0.25%-214.43%15.91%
Earnings Yield
4.87%4.39%0.12%-56.36%9.15%
Efficiency Ratios
Receivables Turnover
6.34 6.34 4.29 3.43 3.56
Payables Turnover
9.62 0.65 3.55 0.79 2.94
Inventory Turnover
0.00 0.00 0.00 0.00 1.13
Fixed Asset Turnover
23.23 23.23 22.64 24.36 20.22
Asset Turnover
0.75 0.75 1.00 0.94 0.37
Working Capital Turnover Ratio
9.36 3.38 6.98 1.24 0.61
Cash Conversion Cycle
19.69 -504.73 -17.75 -358.41 300.07
Days of Sales Outstanding
57.61 57.61 85.05 106.45 102.64
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 321.76
Days of Payables Outstanding
37.92 562.34 102.80 464.86 124.33
Operating Cycle
57.61 57.61 85.05 106.45 424.39
Cash Flow Ratios
Operating Cash Flow Per Share
0.78 0.78 0.65 1.18 1.77
Free Cash Flow Per Share
0.78 0.78 0.65 1.18 1.77
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
3.74K 3.74K 729.22 671.89 2.01K
Capital Expenditure Coverage Ratio
3.74K 3.74K 729.22 671.89 2.01K
Operating Cash Flow Coverage Ratio
0.21 0.21 0.17 0.26 0.66
Operating Cash Flow to Sales Ratio
0.43 0.43 0.29 0.41 0.67
Free Cash Flow Yield
25.62%23.23%14.67%10.30%14.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.53 22.76 800.84 -1.77 10.93
Price-to-Sales (P/S) Ratio
1.67 1.85 2.01 4.02 4.66
Price-to-Book (P/B) Ratio
-1.88 -2.09 -2.34 -5.13 2.93
Price-to-Free Cash Flow (P/FCF) Ratio
3.90 4.30 6.82 9.71 6.99
Price-to-Operating Cash Flow Ratio
3.88 4.30 6.81 9.69 6.99
Price-to-Earnings Growth (PEG) Ratio
-1.85 <0.01 -8.00 <0.01 -0.17
Price-to-Fair Value
-1.88 -2.09 -2.34 -5.13 2.93
Enterprise Value Multiple
7.18 8.88 12.44 12.17 6.40
Enterprise Value
878.04M 929.01M 1.22B 2.40B 1.67B
EV to EBITDA
7.18 8.88 12.44 12.17 6.40
EV to Sales
2.96 3.14 3.46 5.42 4.07
EV to Free Cash Flow
6.91 7.31 11.76 13.11 6.11
EV to Operating Cash Flow
6.91 7.31 11.74 13.09 6.11
Tangible Book Value Per Share
-1.63 -1.63 -1.91 -2.25 4.23
Shareholders’ Equity Per Share
-1.61 -1.61 -1.89 -2.23 4.23
Tax and Other Ratios
Effective Tax Rate
0.66 0.66 0.99 -0.09 0.31
Revenue Per Share
1.83 1.83 2.21 2.85 2.66
Net Income Per Share
0.15 0.15 <0.01 -6.45 1.13
Tax Burden
0.34 0.34 0.01 1.06 0.69
Interest Burden
0.58 0.68 0.68 -4.84 0.97
Research & Development to Revenue
0.32 0.32 0.32 0.26 0.11
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.09 0.06 0.08 0.07 0.07
Income Quality
1.45 5.29 117.67 -0.18 1.56
Currency in USD